Evidence map›Paper›PMID 30594967›Full record

ArticleBreast cancer research and treatment2019

Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence.

Matthew A Lyes, Sturgis Payne, Paul Ferrell, Salvatore V Pizzo, Scott T Hollenbeck, Robin E Bachelder

Open access · hybridAbstract read
In one paragraph

Article in Breast cancer research and treatment, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Exploring the multifaceted role of obesity in breast cancer progression.Frontiers in cell and developmental biology · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. The Importance of Breast Adipose Tissue in Breast Cancer.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Matthew A LyesDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Sturgis PayneDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Paul FerrellDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Salvatore V PizzoDepartment of Pathology, Duke University Medical Center, Durham, NC, USA.
Scott T HollenbeckDivision of Plastic and Reconstructive Surgery, Department of Surgery, Duke University Hospital, Durham, NC, USA.
Robin E BachelderDepartment of Pathology, Duke University Medical Center, Durham, NC, USA. robin.bachelder@duke.edu.ORCID http://orcid.org/0000-0001-7502-2907
Duke Medical Center · USDuke University · USDuke University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMost triple-negative breast cancer (TNBC) patients exhibit an incomplete response to neoadjuvant chemotherapy, resulting in chemo-residual tumor cells that drive tumor recurrence and patient mortality. Accordingly, strategies for eliminating chemo-residual tumor cells are urgently needed. Although stromal cells contribute to tumor cell invasion, to date, their ability to influence chemo-residual tumor cell behavior has not been examined. Our study is the first to investigate cross-talk between adipose-derived stem cells (ASCs) and chemo-residual TNBC cells. We examine if ASCs promote chemo-residual tumor cell proliferation, having implications for tumor recurrence.

methodsASC migration toward chemo-residual TNBC cells was tested in a transwell migration assay. Importance of the SDF-1α/CXCR4 axis was determined using neutralizing antibodies and a small molecule inhibitor. The ability of ASCs to drive tumor cell proliferation was analyzed by culturing tumor cells ± ASC conditioned media (CM) and determining cell counts. Downstream signaling pathways activated in chemo-residual tumor cells following their exposure to ASC CM were studied by immunoblotting. Importance of FGF2 in promoting proliferation was assessed using an FGF2-neutralizing antibody.

resultsASCs migrated toward chemo-residual TNBC cells in a CXCR4/SDF-1α-dependent manner. Moreover, ASC CM increased chemo-residual tumor cell proliferation and activity of extracellular signal-regulated kinase (ERK). An FGF2-neutralizing antibody inhibited ASC-induced chemo-residual tumor cell proliferation.

conclusionsASCs migrate toward chemo-residual TNBC cells via SDF-1α/CXCR4 signaling, and drive chemo-residual tumor cell proliferation in a paracrine manner by secreting FGF2 and activating ERK. This paracrine signaling can potentially be targeted to prevent tumor recurrence.

Indexed as

Drug Resistance, NeoplasmAdipose TissueCell Line, TumorCell MovementCell ProliferationChemokine CXCL12Culture Media, ConditionedFemaleFibroblast Growth Factor 2HumansMAP Kinase Signaling SystemNeoplasm Recurrence, LocalParacrine CommunicationReceptors, CXCR4Stem CellsTriple Negative Breast NeoplasmsChemokine CXCL12Culture Media, ConditionedCXCL12 protein, humanCXCR4 protein, humanFibroblast Growth Factor 2Receptors, CXCR4Adipose-derived stem cells (ASCs)Fibroblast growth factor 2 (FGF2)MigrationProliferationRecurrenceTriple-negative breast cancer (TNBC)

Identifiers

PMID30594967
PMCPMC6422973
OpenAlexW2908010192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.